Siva Therapeutics is developing an elegant, safe and effective cancer treatment termed Targeted Hyperthermia™ (THT), which generates therapeutic heat within solid tumors using SivaRods™ gold nanorods and a SivaLum™ infrared light device. THT has multiple beneficial effects on tumors, and it is more selective than chemotherapy, less destructive than radiation, and without the risks of surgical treatment. This treatment promises to be minimally invasive, to reduce harmful side effects, and to stimulate the immune system. In addition to being more affordable, this technology could deliver faster results than current cancer treatments.
Vision: To develop new cancer therapies that will save lives and not be dreaded by patients.
Mission: To develop a minimally-invasive, practical, safe, cost-effective, and efficacious device therapy for cancer using proprietary nanotechnology. To bring to market a product that will improve the efficacy of current cancer treatments and provide another tool for oncologists. To build a company that will gain and maintain a leadership position in the market for device therapies in cancer treatment.